Corvus Pharmaceuticals Inc buy melinda
Start price
26.04.18
/
50%
€8.85
Target price
26.04.18
€9.92
Performance (%)
0.00%
End price
26.04.18
€8.85
Summary
This prediction ended on 26.04.18 with a price of €8.85. melinda's BUY prediction for Corvus Pharmaceuticals Inc closed unchanged from the start price. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Corvus Pharmaceuticals Inc | 6.499% | 6.499% | 36.559% | 53.012% |
iShares Core DAX® | -5.630% | -5.765% | 8.425% | 8.571% |
iShares Nasdaq 100 | -8.559% | -13.005% | 17.297% | 28.853% |
iShares Nikkei 225® | -9.576% | -9.058% | 3.827% | 0.117% |
iShares S&P 500 | -6.631% | -7.103% | 17.407% | 31.169% |
Comments by melinda for this prediction
In the thread Corvus Pharmaceuticals Inc diskutieren
SektorBiotechnologische und medizinische Forschung
Corvus Pharmaceuticals gibt den Start der klinischen Phase 1 / 1b-Studie des experimentellen Anti-CD73-Antikörpers CPI-006 bei Patienten mit fortgeschrittenem Krebs bekannt
In einer dreiarmigen Studie wird CPI-006 als Monotherapie in Kombination mit dem Adenosinantagonisten CPI-444 und in Kombination mit Pembrolizumab untersucht
(Vom Mitglied beendet)
Stopped prediction by melinda for Corvus Pharmaceuticals Inc
Corvus Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€8.88
26.04.18
26.04.18
€9.92
21.05.18
21.05.18
13.06%
21.05.18
21.05.18
Corvus Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€8.02
04.03.18
04.03.18
€10.10
12.03.18
12.03.18
10.91%
12.03.18
12.03.18